found a significant correlation between NRG1 expression and tumor growth inhibition by the HER3 inhibitory antibody AV-203 [51], and another study demonstrated that HER3 inhibition could be quite effective in NRG1-rearranged cancers [52]. Here, ERBB3 is linked to cancer.